The use of topical capsaicin in managing arthritis pain: A clinician's perspective
References (23)
- et al.
Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy
Diabetes Care
(1992) - et al.
Treatment of painful diabetic neuropathy with topical capsaicin: A multi-center, double-blind, vehicle-controlled study
Arch Intern Med
(1991) - et al.
Treatment of painful diabetic neuropathy with capsaicin 0.075%
J APMA
(1991) - et al.
Topical capsaicin in painful diabetic neuropathy: Controlled study with long-term follow-up
Diabetes Care
(1992) - et al.
Topical capsaicin in painful diabetic neuropathy: Effect on sensory function
Diabetes Care
(1992) - et al.
Topical capsaicin treatment of chronic postherpetic neuralgia
J Am Acad Dermatol
(1989) - et al.
Topical 0.025% capsaicin in chronic post-herpetic neuralgia: Efficacy, predictors of response and long-term course
J Neurol
(1991) - et al.
Post-herpetic neuralgia and topical capsaicin
Pain
(1988) - et al.
A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia
Clin Ther
(1993) - et al.
The postmastectomy pain syndrome and topical capsaicin: A randomized trial
Pain
(1992)
Treatment of reflex sympathetic dystrophy with topical capsaicin: Case report
Pain
Cited by (9)
Topical Analgesics
2009, Perioperative Nursing ClinicsCitation Excerpt :PHN,39–41 chronic distal painful polyneuropathy,42 oral neuropathic pain,43 surgical neuropathic pain,44 and the pain associated with Guillain-Barré syndrome.45 In the treatment of non-neuropathic pain, capsaicin has a role, with evidence of a pain-relieving effect in osteoarthritis,46–51 and neck pain.52 It appears that capsaicin achieves its pain-relieving effect by reversibly depleting sensory nerve endings of substance P53,54 and by reducing the density of epidermal nerve fibers, also in a reversible fashion.55
Topical analgesic agents
2009, Current Therapy in PainTopical Analgesic Agents
2008, Clinics in Geriatric MedicineCitation Excerpt :It is available commercially as a 0.025% and a 0.075% cream. It reduces the pain of diabetic neuropathy [19–22], postherpetic neuralgia [23–25], surgical neuropathic pain [26], chronic distal painful polyneuropathy [27], osteoarthritis [28–33], and neck pain [34]. In practice, repeated application of capsaicin is required before clinical effect may be apparent.
Topical Analgesics
2007, Anesthesiology ClinicsCitation Excerpt :It has now been shown to reduce the pain associated with painful diabetic neuropathy [35–38], PHN [39–41], chronic distal painful polyneuropathy [42], oral neuropathic pain [43], surgical neuropathic pain [44], and the pain associated with Guillain-Barré syndrome [45]. In the treatment of non-neuropathic pain, capsaicin has a role, with evidence of a pain-relieving effect in osteoarthritis [46–51] and neck pain [52]. It appears that capsaicin achieves its pain-relieving effect by reversibly depleting sensory nerve endings of substance P [53,54] and by reducing the density of epidermal nerve fibers, also in a reversible fashion [55].
Topical Analgesics
2007, Medical Clinics of North AmericaCitation Excerpt :It has now been shown to reduce the pain associated with painful diabetic neuropathy [35–38], PHN [39–41], chronic distal painful polyneuropathy [42], oral neuropathic pain [43], surgical neuropathic pain [44], and the pain associated with Guillain-Barré syndrome [45]. In the treatment of non-neuropathic pain, capsaicin has a role, with evidence of a pain-relieving effect in osteoarthritis [46–51] and neck pain [52]. It appears that capsaicin achieves its pain-relieving effect by reversibly depleting sensory nerve endings of substance P [53,54] and by reducing the density of epidermal nerve fibers, also in a reversible fashion [55].
Pharmacologic management of common musculoskeletal disorders in women
1997, Journal of Nurse-Midwifery
Supported by Genderm Corporation, Lincolnshire, IL, and Knoll Pharmaceutical Company, Whippany, NJ.